# Ernexa Therapeutics Inc.: Form 8-K, filed Oct 11, 2011

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2011-10-11
- Accepted by EDGAR: Oct 11, 2011, 12:10 ET
- Period: 2011-10-04
- Accession: 0001019687-11-003189
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968711003189/ntn_8k-100411.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968711003189/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968711003189/ntn_8k-100411.htm

Filed Oct 11, 2011.
Source: SEC EDGAR, the filing index for accession 0001019687-11-003189. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.